2013
DOI: 10.1016/j.ijcard.2012.09.180
|View full text |Cite
|
Sign up to set email alerts
|

Strict application of NICE Clinical Guideline 95 ‘chest pain of recent onset’ leads to over 90% increase in cost of investigation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
6
0

Year Published

2014
2014
2018
2018

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 4 publications
0
6
0
Order By: Relevance
“…Obstructive CAD was only confirmed in 23% of patients with a high PTP risk score and 9% in those with a moderate PTP risk score. 5 This may reflect a lower incidence of disease in our population, but more likely confirms that the PTP risk score overestimates the true risk. This has now been conclusively demonstrated in the international registry, CONFIRM, in 14,048 patients who underwent CCTA.…”
mentioning
confidence: 64%
See 1 more Smart Citation
“…Obstructive CAD was only confirmed in 23% of patients with a high PTP risk score and 9% in those with a moderate PTP risk score. 5 This may reflect a lower incidence of disease in our population, but more likely confirms that the PTP risk score overestimates the true risk. This has now been conclusively demonstrated in the international registry, CONFIRM, in 14,048 patients who underwent CCTA.…”
mentioning
confidence: 64%
“…Strict application of the current NICE guideline would result in substantial (42-93%) cost increase 5,19 because of patients with high PTP risk scores being referred directly for invasive coronary angiography. CCTA is a very fast test, both in terms of acquisition of the images and reporting; hence, its low unit cost per scan (£173) compared with stress echo (£236), nuclear scintigraphy (£293) and invasive angiography (£1052) based on the NICE costing report.…”
mentioning
confidence: 99%
“…Only the DFM and DCS models were studied in a letter to the Editor. The report on these models showed that by following the standard diagnostic pathway, the total cost of examining all patients was £102,731, compared to £198,495 for the diagnostic pathway proposed by the NICE chest pain guidance 32.…”
Section: Discussionmentioning
confidence: 99%
“…This was due to our previous studies which demonstrated that the NICE RS overestimated the risk of CAD. 6 However, this did not infl uence or bias our results as we compared the risk scores from two different guidelines and not their choice of investigation.…”
Section: Limitationsmentioning
confidence: 99%
“…5 Our previous studies demonstrated that the NICE RS overestimates incidence of disease. 6 Hence we have locally expanded the use of CTCA to patients with intermediate RS and the functional imaging tests to patients with high RS. Our aim in this study was to establish whether there is a difference between the ESC and NICE RS models.…”
Section: Introductionmentioning
confidence: 99%